期刊文献+

浸润性乳腺癌PELP1/MNAR表达与雌激素受体、人表皮生长因子受体2、Ki-67表达及PIK3CA基因突变的相关性分析 被引量:2

Analysis of the correlation of PELP1/MNAR expression with expressions of estrogen receptor,human epidermal growth factor receptor 2,Ki-67 and PIK3CA gene mutation in invasive breast cancer
原文传递
导出
摘要 目的探讨浸润性乳腺癌PELP1/MNAR表达与雌激素受体(ER)、Ki-67和人表皮生长因子受体2(HER2)表达及与PIK3CA基因突变的相关性。方法收集山西省大同市第五人民医院2008年1月至2018年12月80例原发浸润性乳腺癌患者石蜡包埋组织标本,应用免疫组织化学EliVision二步法检测PELP1/MNAR蛋白表达,采用聚合酶链反应(PCR)-Sanger测序检测PIK3CA基因突变情况。比较ER、Ki-67、HER2不同表达状态及PIK3CA基因是否突变患者间PELP1/MNAR表达情况,分析各指标与PELP1/MNAR表达的相关性。结果ER阳性[86.1%(31/36)比59.1%(26/44)]、Ki-67高表达[100.0%(13/13)比65.7%(44/67)]、HER2阳性[81.0%(34/42)比60.5%(23/38)]患者PELP1/MNAR蛋白高表达率较高,差异均有统计学意义(均P<0.05)。PIK3CA突变型和野生型患者PELP1/MNAR蛋白高表达率差异无统计学意义[60.0%(12/20)比75.0%(45/60),P=0.199]。PELP1/MNAR的表达与ER表达水平呈负相关(r=-0.195,P<0.05),与Ki-67表达水平呈正相关(r=0.198,P<0.05),与HER2表达水平呈正相关(r=0.225,P<0.05),与淋巴结转移呈负相关(r=-0.269,P<0.05)。结论浸润性乳腺癌PELP1/MNAR的表达与ER表达水平负相关,与Ki-67、HER2表达水平正相关。PELP1/MNAR表达与PIK3CA基因突变无相关性,二者可能在乳腺癌PI3K-AKT-mTOR调节途径中各自发挥作用。 Objective To investigate the correlation of PELP1/MNAR expression with expressions of estrogen receptor(ER),Ki-67,human epidermal growth factor receptor 2(HER2)and PIK3CA gene mutation.Methods A total of 80 paraffin-embedded tissue specimens of primary invasive breast cancer patients in the Fifth People's Hospital of Datong in Shanxi Province from January 2008 to December 2018 were collected.The expression of PELP1/MNAR was examined by immunohistochemistry EliVision tow-step method.The polymerase chain reaction(PCR)-Sanger sequencing method was used to detect the mutation of PIK3CA gene.The expressions of PELP1/MNAR among patients with different expression status of ER,Ki-67,HER2 and with or without PIK3CA gene mutation were compared,and the correlations between each index and the expression of PELP1/MNAR were analyzed.Results The high expression rates of PELP1/MNAR protein in patients with ER-positive[86.1%(31/36)vs.59.1%(26/44)],Ki-67 high expression[100.0%(13/13)vs.65.7%(44/67)],HER2-positive[81.0%(34/42)vs.60.5%(23/38)]were high,and the differences were statistically significant(all P<0.05).There was no significant difference in the high expression rate of PELP1/MNAR protein between patients with mutant and wild-type PIK3CA[60.0%(12/20)vs.75.0%(45/60),P=0.199].The expression of PELP1/MNAR was negatively correlated with the expression level of ER(r=-0.195,P<0.05),positively correlated with the expression level of Ki-67(r=0.198,P<0.05),positively correlated with the expression level of HER2(r=0.225,P<0.05),and negatively correlated with lymph node metastasis(r=-0.269,P<0.05).Conclusions The expression of PELP1/MNAR in invasive breast cancer is negatively correlated with the expression level of ER,and positively correlated with the expression level of Ki-67 and HER2.There is no correlation between PELP1/MNAR expression and PIK3CA gene mutation,and the two may play their own role in the PI3K-AKT-mTOR regulatory pathway of breast cancer.
作者 安晓燕 郭文慧 王腾伟 付有 姜汉尧 田秀娟 An Xiaoyan;Guo Wenhui;Wang Tengwei;Fu You;Jiang Hanyao;Tian Xiujuan(Department of Pathology,the Fifth People's Hospital of Datong in Shanxi Province,Datong 037006,China)
出处 《肿瘤研究与临床》 CAS 2021年第12期928-932,共5页 Cancer Research and Clinic
基金 山西省应用基础研究项目(201801D121288)。
关键词 乳腺肿瘤 受体 雌激素 KI-67抗原 基因 ERBB-2 PELP1/MNAR Breast neoplasms Receptors,estrogen Ki-67 antigen Genes,erbB-2 PELP1/MNAR
  • 相关文献

参考文献4

二级参考文献44

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 3<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 4Volinia S, Hiles I,Ormondroyd E,et al. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene[J]. Genomics,1994,24(3) :472- 477.
  • 5Kang S, Bader A G, Vogt P K. Phosphatidylinositol 3-kinase mutations identified in hunman cancer are oncogenic[J]. Proc Natl Acad Sci U S A, 2005,102 (3) : 802-807.
  • 6Cantley L C. The phosphoinositide 3-kinase pathway[J]. Science,2002,296(5573) :1655-1657.
  • 7Ma Y Y,Wei S J,Lin Y C, et al. PIK3CA as a oncogene in cervical cancer[J]. Oncogene,2000,19(23) :2739-2744.
  • 8Woenckhaus J, Steger K,Werner E, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma [J]. J Pathol, 2002,198(3) :335- 342.
  • 9Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers[J]. Science,2004, 304(5670) :554.
  • 10Campbell I G,Russell S E,Choong D Y,et al. Mutation of the PIK3CA gene in ovarian and breast cancer[J]. Cancer Res, 2004,64(21) :7678-7681.

共引文献262

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部